Blog
RSS FeedPosted by Michael Wonder on 17 Jun 2026
FDA approves first single dose generic treatment for influenza
17 June 2026 - The US FDA today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment ...
Posted by Michael Wonder on 04 Jun 2026
Why Canada has generic Ozempic, and the US doesn't
3 June 2026 - Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help ...
Posted by Michael Wonder on 20 May 2026
TrumpRx adds generic drugs, with Mark Cuban, GoodRx and Amazon
18 May 2026 - President Trump announced the addition of 600 medicines to his online drugstore as he appeals to Americans ...
Posted by Michael Wonder on 15 May 2026
Apotex launches Apo‑Semaglutide Injection, a generic equivalent of Ozempic, in Canada
14 May 2026 - Apotex today announced the commercial launch of Apo‑Semaglutide Injection – a generic equivalent of Ozempic. ...
Posted by Michael Wonder on 03 May 2026
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic
1 May 2026 - Apotex today announced that Health Canada has approved Apo‑Semaglutide Injection, a generic equivalent of Ozempic (semaglutide injection). ...
Posted by Michael Wonder on 29 Apr 2026
Canada becomes the first G7 country to approve a generic version of semaglutide
28 April 2026 - Today, Health Canada authorised a generic semaglutide injection. This is the first generic semaglutide authorised by Health ...
Posted by Michael Wonder on 07 Apr 2026
FDA approves first generic dapagliflozin tablets
7 April 2026 - FDA approves multiple generics of Farxiga. ...
Posted by Michael Wonder on 04 Mar 2026
FDA approves first generic of Flovent HFA for treatment of asthma
3 March 2026 - Today, the US FDA approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 mcg/actuation, ...
Posted by Michael Wonder on 12 Feb 2026
Pharma group warns drug price cuts threaten industry investment
10 February 2026 - KPBMA demands postponement, impact assessments, and policy dialogue to protect R&D and health security amid pricing reforms. ...
Posted by Michael Wonder on 28 Dec 2025
Drug makers push back against government’s generic price cut plan
28 December 2025 - Pharma industry warns lower generic prices will curb R&D, health officials cite unchanged pricing since 2012. ...
Posted by Michael Wonder on 30 Nov 2025
Korea launches sweeping drug pricing reform to curb generic dominance
29 November 2025 - The Government will launch a large scale overhaul of the drug pricing system starting in the ...
Posted by Michael Wonder on 26 Dec 2024
FDA approves first generic of once daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes
23 December 2024 - Today, the US FDA approved the first generic referencing Victoza (liraglutide injection) 18 mcg/3 mL, a ...
Posted by Michael Wonder on 22 Sep 2024
The impact of generic entry of pharmaceuticals in Australia
20 September 2024 - In this article, we estimate the initial and temporal impacts of generic entry on benchmark drug prices ...
Posted by Michael Wonder on 14 Aug 2024
The FDA should withdraw approval of more than 400 tainted medicines
12 August 2024 - When the FDA learned that a testing facility in India had submitted fraudulent data for more ...
Posted by Michael Wonder on 07 Feb 2024
FDA and EMA launch parallel scientific advice pilot program for complex generics
7 February 2024 - CDER’s Office of Generic Drugs and the EMA launched a voluntary pilot program to facilitate concurrent discussions ...